Francis MJ - Search Results

1

Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties.

Beesley KM, Francis MJ, Clarke BE, Beesley JE, Dopping-Hepenstal PJ, Clare JJ, Brown F, Romanos MA. Beesley KM, et al. Among authors: francis mj. Biotechnology (N Y). 1990 Jul;8(7):644-9. doi: 10.1038/nbt0790-644. Biotechnology (N Y). 1990. PMID: 1369994

2

Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria.

Clarke BE, Brown AL, Grace KG, Hastings GZ, Brown F, Rowlands DJ, Francis MJ. Clarke BE, et al. Among authors: francis mj. J Gen Virol. 1990 May;71 ( Pt 5):1109-17. doi: 10.1099/0022-1317-71-5-1109. J Gen Virol. 1990. PMID: 1693163

3

Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted.

Brown AL, Francis MJ, Hastings GZ, Parry NR, Barnett PV, Rowlands DJ, Clarke BE. Brown AL, et al. Among authors: francis mj. Vaccine. 1991 Aug;9(8):595-601. doi: 10.1016/0264-410x(91)90248-5. Vaccine. 1991. PMID: 1722937

4

Immunological properties of hepatitis B core antigen fusion proteins.

Francis MJ, Hastings GZ, Brown AL, Grace KG, Rowlands DJ, Brown F, Clarke BE. Francis MJ, et al. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2545-9. doi: 10.1073/pnas.87.7.2545. Proc Natl Acad Sci U S A. 1990. PMID: 2320575 Free PMC article.

5

Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.

Clarke BE, Newton SE, Carroll AR, Francis MJ, Appleyard G, Syred AD, Highfield PE, Rowlands DJ, Brown F. Clarke BE, et al. Among authors: francis mj. Nature. 1987 Nov 26-Dec 2;330(6146):381-4. doi: 10.1038/330381a0. Nature. 1987. PMID: 2446137

6

Serological prospects for peptide vaccines against foot-and-mouth disease virus.

Parry NR, Ouldridge EJ, Barnett PV, Clarke BE, Francis MJ, Fox JD, Rowlands DJ, Brown F. Parry NR, et al. Among authors: francis mj. J Gen Virol. 1989 Nov;70 ( Pt 11):2919-30. doi: 10.1099/0022-1317-70-11-2919. J Gen Virol. 1989. PMID: 2479714

7

Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides.

Francis MJ, Hastings GZ, Clarke BE, Brown AL, Beddell CR, Rowlands DJ, Brown F. Francis MJ, et al. Immunology. 1990 Feb;69(2):171-6. Immunology. 1990. PMID: 2155177 Free PMC article.

8

Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus.

Francis MJ, Hastings GZ, Brown F, McDermed J, Lu YA, Tam JP. Francis MJ, et al. Immunology. 1991 Jul;73(3):249-54. Immunology. 1991. PMID: 1652552 Free PMC article.

9

Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants.

Francis MJ, Hastings GZ, Syred AD, McGinn B, Brown F, Rowlands DJ. Francis MJ, et al. Nature. 1987 Nov 12-18;330(6144):168-70. doi: 10.1038/330168a0. Nature. 1987. PMID: 2444892

10

Qualitative and quantitative differences in the immune response to foot-and-mouth disease virus antigens and synthetic peptides.

Francis MJ, Fry CM, Rowlands DJ, Brown F. Francis MJ, et al. J Gen Virol. 1988 Oct;69 ( Pt 10):2483-91. doi: 10.1099/0022-1317-69-10-2483. J Gen Virol. 1988. PMID: 2844964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters